| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 11/04/2008 | CA2256328C Novel n-acylsulphonamides, novel mixtures of herbicides and antidotes and their use |
| 10/30/2008 | WO2008131149A2 Crystal forms of saxagliptin and processes for preparing same |
| 10/30/2008 | WO2008131000A2 7-substituted indole mcl-1 inhibitors |
| 10/30/2008 | WO2008130970A1 7-nonsubstituted indole mcl-1 inhibitors |
| 10/30/2008 | WO2008130853A1 Hydrazides and their use as metabotropic glutamate receptor potentiators - 681 |
| 10/30/2008 | WO2008130348A1 Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases |
| 10/30/2008 | WO2008129075A1 Substituted 3-(4-hydroxyphenyl)-indolin-2-one-compounds |
| 10/30/2008 | WO2008064320A3 Hydrindane analogs having sphingosine 1-phosphate receptor agonist activity |
| 10/30/2008 | WO2008022204A3 Thiourea compounds |
| 10/30/2008 | WO2007109211A8 1-oxo-isoindoline compounds for the treatment of spinal muscular atrophy and other uses |
| 10/30/2008 | US20080269470 Dianionic chelating ligands with a bridged-bis-bi-aryl structure; For catalytic polymerization of ethylene/olefin copolymers |
| 10/30/2008 | US20080269312 1-(4-tert-Butyl-benzenesulfonyl)-2,3-dihydro-1H-indole-2-carboxylic acid methyl ester; 5-Bromo-1-(4-tert-butyl-benzenesulfonyl)-2,3-dihydro-1H-indole-2-carboxylic acid; therapeutic treatment in immune-mediated diseases, e.g. intestinal disorders, such as autoimmune and inflammatory diseases |
| 10/30/2008 | US20080269282 Including semicarbazide-sensitive amine oxidase (vascular adhesion protein-1, VAP-I), and therapeutic use in inflammatory diseases, diabetes and its associated complications, atherosclerosis, neurodegenerative diseases, obesity, hypertension and cancer; N1-hydroxy-N2-[(4-bromophenyl)carbonyl]glycinamide |
| 10/30/2008 | US20080269237 Histone deacetylase inhibitor; anticancer agents; antiproliferative agents; antitumor agents; psoriasis; piperazine compound containing a carbamic acid group |
| 10/30/2008 | US20080269228 Hydrazide-containing hepatitis c serine protease inhibitors |
| 10/30/2008 | US20080269220 Antidiabetic agents; obesity; insulin resistance; neurodegenerative diseases; Alzheimer's disease |
| 10/30/2008 | US20080269200 Antiinflammatory agents; tissue repair; rheumatic disorders; asthma; chronic onstructive pulmonary disease; osteoporosis; psoriasis; Alzheimer's disease; transplant rejection; stroke; antidiabetic agents; glomerulonephritis; anticancer agents |
| 10/30/2008 | US20080269197 antipsychotic agents; phenylsulfonyl compounds; 7-Methoxy-8-(3-phenoxy-benzenesulfonyl)-2,3,4,5-tetrahydro-1H-3-benzazepine; schizophrenia |
| 10/30/2008 | US20080268519 Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides |
| 10/30/2008 | US20080268518 Non-natural amino acid polypeptides and modified non-natural amino acid polypeptides, therapeutic, diagnostic, and other biotechnology uses |
| 10/30/2008 | US20080268284 Anthrcene bonded to a carbazole through an aryl amine; emits blue light with high color purity; reduced power consumption |
| 10/30/2008 | US20080267981 Treating neoplastic diseases with antibody-cytotoxin conjugate (duocarmycins); integrins; 3-[5-(1-(3-aminopropyl)indole-2-carbonyl)aminoindole-2-carbonyl]-1-(chloromethyl)-5-hydroxy-1,2-dihydro-3H-benz[e]indole |
| 10/30/2008 | US20080267879 Novel Imaging Tracers for Early Detection and Treatment of Amyloid Plaques Caused by Alzheimer's Disease and Related Disorders |
| 10/30/2008 | US20080265755 Biscarbazol-9-Yl-Substituted Triarylamine-Containing Polymers and Electronic Devices |
| 10/30/2008 | US20080264487 Photoelectric Conversion Devices |
| 10/30/2008 | CA2685153A1 Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases |
| 10/30/2008 | CA2684552A1 Substituted 3-(4-hydroxyphenyl)-indolin-2-one compounds |
| 10/30/2008 | CA2683512A1 Process for the manufacture of non-steroidal anti-inflammatory agents and intermediates thereof |
| 10/30/2008 | CA2682356A1 7-substituted indole mcl-1 inhibitors |
| 10/30/2008 | CA2682354A1 7-nonsubstituted indole mcl-1 inhibitors |
| 10/29/2008 | EP1985613A2 Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device in which the anthracene derivative is used |
| 10/29/2008 | EP1985612A1 Arymethylen substituted N-Acyl-gamma-aminoalcohols |
| 10/29/2008 | EP1984335A1 Improved process for the preparation of stable nitroxyl radicals |
| 10/29/2008 | EP1984334A2 Indole-3-carboxylic acid amide, ester, thioamide and thiol ester compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (s1p) receptor antagonist biological activity |
| 10/29/2008 | EP1984333A1 Substituted benzofurans, benzothiophenes, benzoselenophenes and indoles and their use as tubulin polymerisation inhibitors |
| 10/29/2008 | EP1984332A2 Methods for treating hepatitis c |
| 10/29/2008 | EP1809602B1 Indole derivatives useful as progesterone receptor modulators |
| 10/29/2008 | EP1751106B1 Piperazine derivatives of alkyl oxindoles |
| 10/29/2008 | EP1751105B1 Piperazine derivatives of alkyl oxindoles |
| 10/29/2008 | EP1727798B1 Novel aryl-containing 5-acylindolinones, the production thereof and their use as medicaments |
| 10/29/2008 | CN101296903A Novel indole-containing beta agonists, method for producing them and their use as drugs |
| 10/29/2008 | CN101293865A Organic compound and anthracene derivative |
| 10/29/2008 | CN101293864A Compound having affinity with brain A beta plaque, preparation method and application thereof |
| 10/29/2008 | CN100429202C Preparation method of amorphous fluvastatin sodium |
| 10/29/2008 | CN100429201C Heterocyclic compounds and methods of use thereof |
| 10/28/2008 | USRE40558 Peroxisome proliferator-activated receptors agonists/ antagonists; 2-methyl-6-[3-(quinolin-2-ylmethoxy)-propoxymethyl]-benzoic acid; eating diorders; physiological detrimental blood level of insulin, glucose, free fatty acids, or triglycerides; hyperlipemia; atherosclerosis; antidiabetic agent |
| 10/28/2008 | US7442808 e.g. 3-(indan-1-yloxy)-8-(oxazolidin-2,4-dion-5-yl)-5,6,7,8-tetrahydroquinoline; with other active ingredients; agonists of G-protein coupled receptor 40 (GPR40); antidiabetic, hypoglycemic agent; non-insulin dependent diabetes, obesity, hyperlipemia |
| 10/28/2008 | US7442805 Substituted sulfonamide-indoles |
| 10/28/2008 | US7442803 Aromatic amine compound, and light emitting element, light emitting device, and electronic device using aromatic amine compound |
| 10/28/2008 | US7442794 Stereoisomers ; reacting with Lewis acid; purification |
| 10/28/2008 | US7442790 Caspase inhibitors and uses thereof |
| 10/28/2008 | US7442708 Inhibitors of basic fibroblast growth factors (FGFs); treating cancer, rheumatoid arthritis, inflammatory bowel disease, cardiovascular disorders, diabetic retinopathy, achondroplasia, hypochondoplasia, or thanathophoric dysplasia |
| 10/28/2008 | US7442447 Binaphthol based chromophores for the fabrication of blue organic light emitting diodes |
| 10/23/2008 | WO2008127139A1 Indicyanine dyes and the derivatives thereof for analysing biological micromolecules |
| 10/23/2008 | WO2008126901A1 Nitrogen-containing heterocyclic compound and pharmaceutical composition containing the same |
| 10/23/2008 | WO2008126898A1 (aza)indole derivative and use thereof for medical purposes |
| 10/23/2008 | WO2008125988A1 Novel derivatives of psammaplin a, a method for their synthesis and their use for the prevention or treatment of cancer |
| 10/23/2008 | WO2008125568A1 Process for preparing precursors of carbenes of caac type and use thereof for preparing said carbenes |
| 10/23/2008 | WO2008125207A1 A transition metal catalyzed synthesis of n-aminoindoles |
| 10/23/2008 | WO2008024970A3 Tetrahydroindolone and tetrahydroindazolone derivatives |
| 10/23/2008 | WO2008021849A3 Novel compounds as antagonists or inverse agonists at opioid receptors |
| 10/23/2008 | US20080262245 Dissolving, stirring in methanol; concentrating into a gel; isolation of residue; drying under vacuum or filtration |
| 10/23/2008 | US20080262244 Process for the Preparation of Indolone Derivative |
| 10/23/2008 | US20080262243 Reacting a vinyl sulfone compound with imide compound in presence of catalyst |
| 10/23/2008 | US20080262224 Method of Preparation of Benzofuran-2-Carboxylic Acid -Amide |
| 10/23/2008 | US20080262139 A novolak structure modified by nitrogen-containing or silicon-containing compound may collocate with inorganic powder; high heat resistance and glass transition temperature, low expansion, hydrophobic; prepregs used in copper clad laminates or printed circuit plates |
| 10/23/2008 | US20080262069 carvedilol phosphate salts, which include novel crystalline forms of carvedilol dihydrogen phosphate (i.e., dihydrogen phosphate salt of 1-(carbazol-4-yloxy-3-[[2-(o-methoxyphenoxy) ethyl]amino]-2-propanol) and/or carvedilol hydrogen phosphate, etc.), and/or solvates , compositions containing compounds |
| 10/23/2008 | US20080262035 Amide Derivatives as Inhibitors of Histone Deacetylase |
| 10/23/2008 | US20080261994 4-[5-((1S,2R)-1-Carboxy-2-phenyl-cyclopropylsulfamoyl)-thiophen-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester; aggrecanase and matrix metalloproteinase (with zinc in the catalytic active center) inhibitor; antiarthritic agent: osteoarthritis, rheumatoid arthritis |
| 10/23/2008 | US20080261944 Indole Derivatives as Antiviral Agents |
| 10/23/2008 | US20080261917 Prodrug; novel series of compounds which inhibit the MDM2-p53 interaction and have in vitro activity exerting an anti-tumour effect; cancer |
| 10/23/2008 | US20080260685 Prodrugs of cc-1065 analogs |
| 10/23/2008 | CA2683578A1 A transition metal catalyzed synthesis of n-aminoindoles |
| 10/23/2008 | CA2682391A1 (aza)indole derivative and use thereof for medical purposes |
| 10/23/2008 | CA2678833A1 Novel derivatives of psammaplin a, a method for their synthesis and their use for the prevention or treatment of cancer |
| 10/22/2008 | EP1982976A1 Process for the manufacture of non-steroidal anti-inflammatory agents and intermediates thereof |
| 10/22/2008 | EP1981846A2 Markers, method for manufacturing them and their applications |
| 10/22/2008 | EP1981831A2 Kit for automated resolving agent selection and method thereof |
| 10/22/2008 | EP1981534A2 Indoleamine 2,3-dioxygenase pathways in the generation of regulatory t cells |
| 10/22/2008 | EP1654228B1 Tetrahydrocarbazole derivatives and their pharmaceutical use |
| 10/22/2008 | EP1603562A4 Sulfonyl-amidino containing and tetrahydropyrimidino containing compounds as factor xa inhibitors |
| 10/22/2008 | EP1458394B1 Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer s disease and conditions associated with glycogen synthase kinase-3 |
| 10/22/2008 | EP1417190B1 Substituted piperazines as modulators of the melanocortin receptor |
| 10/22/2008 | CN101291916A 9-aminocarbonylsubstituted derivatives of glycylcyclines |
| 10/22/2008 | CN101291909A Processes and intermediates |
| 10/22/2008 | CN101291908A Immunosuppressant compounds and compositions |
| 10/22/2008 | CN101291670A Carbazole derivatives as functional 5-HT6 ligands |
| 10/22/2008 | CN101289403A Cyclopentaphenanthrene-based compound and organoelectroluminescent device employing the same |
| 10/22/2008 | CN100428528C Organic electroluminescence device |
| 10/22/2008 | CN100427467C Compound and organic LED and display containing the compound |
| 10/22/2008 | CN100427466C Compound of 2-benzoxyacrylate and application thereof |
| 10/22/2008 | CN100427465C N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses |
| 10/22/2008 | CN100427085C (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof |
| 10/21/2008 | US7439371 N-methyl-2-(3-{[4-(4-methyl-piperazin-1-yl)-phenylamino]-methylene}-2-oxo-2,3-dihydro-1H-indol-6-ylsulfanyl)-benzamide for modulating tyrosine kinase signal transduction to regulate, modulate and/or inhibit abnormal cell proliferation |
| 10/21/2008 | US7439359 Antiproliferative agents; antitumor agents; binding to chaperone protein |
| 10/21/2008 | US7439249 such as 2-(7-acetylamino-1-furano-2-ylmethyl-2,4-dioxo-1,4-dihydro-2H-quinazolin-3-yl)-succinic acid; for treatment of autoimmune diseases, proliferative diseases, angiogenic disorders, and/or cancers; catheters, prosthetics |
| 10/21/2008 | US7438894 Polyhydroxy-polysulphonyl-glucose-benz(e)indoles; absorb and fluoresce in visible region; optical diagnosis of renal and cardiac diseases; tomography; magnetic resonance imaging |
| 10/21/2008 | CA2330974C Energy transfer assay method and reagent |
| 10/16/2008 | WO2008123404A1 Cyanine compound, optical filter using the compound and optical recording material |
| 10/16/2008 | WO2008123207A1 Ornithine derivative |